Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC25A30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RALGPS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP5M1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
HLA-DQB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PASK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPR107 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC30A4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRTC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB8OS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SORL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GREB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLA-DRA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLSCR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC49 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on